Ischemic Stroke
Conditions
Interventions
Anisodine Hydrobromide Injection group:Nil
Basic therapy group:Nil
Sponsors
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. For patients diagnosed with ischemic stroke (in line with the diagnostic criteria of ischemic stroke in the ''China Guidelines for Diagnosis and Treatment of Acute Ischemic Stroke 2018''), CT/MRI examinations should be performed to exclude cerebral hemorrhage; 2. Aged >= 18 years, gender is not limited; 3. The interval from onset to admission is less than or equal to 30 days.
Exclusion criteria
Exclusion criteria: 1. Neuroimaging examination (CT/MRI) confirmed acute intracranial hemorrhage, tumor, encephalitis or other non-vascular intracranial lesions; 2. Those with a history of glaucoma, prostatic hypertrophy, pyloric obstruction, bleeding disorders, and those who may be allergic to anisodine; 3. Pregnant and lactating patients; 4. Patients with severe dysfunction of vital organs; 5. Critically ill with a life expectancy of less than three months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The one-year survival rate after onset;Proportion of 30-day unplanned readmissions; | — |
Secondary
| Measure | Time frame |
|---|---|
| Recurrence of stroke;Changes of NIHSS scores from baseline in the two groups at discharge and comparison between groups;Incidence of hemorrhagic transformation after cerebral infarction during hospitalization;Safety observation indicators; | — |
Countries
China
Contacts
Public ContactWang Qiaoling
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Outcome results
None listed